Asset Management
Compare Stocks
2 / 10Stock Comparison
IPCX vs LAZ
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
IPCX vs LAZ — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Asset Management | Financial - Capital Markets |
| Market Cap | $76K | $4.52B |
| Revenue (TTM) | $0.00 | $3.19B |
| Net Income (TTM) | $-1M | $237M |
| Gross Margin | — | 31.8% |
| Operating Margin | — | 13.0% |
| Forward P/E | — | 16.2x |
| Total Debt | $127K | $2.58B |
| Cash & Equiv. | $0.00 | $1.50B |
IPCX vs LAZ — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 25 | May 26 | Return |
|---|---|---|---|
| Inflection Point Ac… (IPCX) | 100 | 101.1 | +1.1% |
| Lazard Ltd (LAZ) | 100 | 100.2 | +0.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IPCX vs LAZ
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IPCX is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 0.04
- Lower volatility, beta 0.04, current ratio 0.01x
- Beta 0.04, current ratio 0.01x
LAZ carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 105.3% 10Y total return vs IPCX's -0.1%
- 3.6% yield; 1-year raise streak; the other pay no meaningful dividend
- +15.3% vs IPCX's -0.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Stability / Safety | Beta 0.04 vs LAZ's 1.78 | |
| Dividends | 3.6% yield; 1-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +15.3% vs IPCX's -0.1% | |
| Efficiency (ROA) | 5.2% ROA vs IPCX's -0.5% |
IPCX vs LAZ — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
IPCX vs LAZ — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Insufficient data to determine a leader in this category.
Income & Cash Flow (Last 12 Months)
LAZ and IPCX operate at a comparable scale, with $3.2B and $0 in trailing revenue.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $0 | $3.2B |
| EBITDAEarnings before interest/tax | -$3M | $384M |
| Net IncomeAfter-tax profit | -$1M | $237M |
| Free Cash FlowCash after capex | -$1M | $519M |
| Gross MarginGross profit ÷ Revenue | — | +31.8% |
| Operating MarginEBIT ÷ Revenue | — | +13.0% |
| Net MarginNet income ÷ Revenue | — | +7.4% |
| FCF MarginFCF ÷ Revenue | — | +15.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | -43.8% |
Valuation Metrics
IPCX leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $75,530 | $4.5B |
| Enterprise ValueMkt cap + debt − cash | $202,414 | $5.6B |
| Trailing P/EPrice ÷ TTM EPS | -804.69x | 22.16x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.18x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 12.43x |
| Price / SalesMarket cap ÷ Revenue | — | 1.42x |
| Price / BookPrice ÷ Book value/share | — | 5.17x |
| Price / FCFMarket cap ÷ FCF | — | 8.94x |
Profitability & Efficiency
Evenly matched — IPCX and LAZ each lead in 2 of 4 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), LAZ scores 5/9 vs IPCX's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | +26.7% |
| ROA (TTM)Return on assets | -0.5% | +5.2% |
| ROICReturn on invested capital | — | +9.5% |
| ROCEReturn on capital employed | — | +9.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 |
| Debt / EquityFinancial leverage | — | 2.61x |
| Net DebtTotal debt minus cash | $126,884 | $1.1B |
| Cash & Equiv.Liquid assets | $0 | $1.5B |
| Total DebtShort + long-term debt | $126,884 | $2.6B |
| Interest CoverageEBIT ÷ Interest expense | — | 4.74x |
Total Returns (Dividends Reinvested)
LAZ leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LAZ five years ago would be worth $12,480 today (with dividends reinvested), compared to $9,990 for IPCX. Over the past 12 months, LAZ leads with a +15.3% total return vs IPCX's -0.1%. The 3-year compound annual growth rate (CAGR) favors LAZ at 23.0% vs IPCX's -0.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +1.5% | -2.3% |
| 1-Year ReturnPast 12 months | -0.1% | +15.3% |
| 3-Year ReturnCumulative with dividends | -0.1% | +85.9% |
| 5-Year ReturnCumulative with dividends | -0.1% | +24.8% |
| 10-Year ReturnCumulative with dividends | -0.1% | +105.3% |
| CAGR (3Y)Annualised 3-year return | -0.0% | +23.0% |
Risk & Volatility
IPCX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
IPCX is the less volatile stock with a 0.04 beta — it tends to amplify market swings less than LAZ's 1.78 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IPCX currently trades 99.5% from its 52-week high vs LAZ's 81.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.04x | 1.78x |
| 52-Week HighHighest price in past year | $10.35 | $58.75 |
| 52-Week LowLowest price in past year | $10.05 | $38.67 |
| % of 52W HighCurrent price vs 52-week peak | +99.5% | +81.8% |
| RSI (14)Momentum oscillator 0–100 | 67.5 | 50.6 |
| Avg Volume (50D)Average daily shares traded | 63K | 1.5M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
LAZ is the only dividend payer here at 3.65% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $48.50 |
| # AnalystsCovering analysts | — | 29 |
| Dividend YieldAnnual dividend ÷ price | — | +3.6% |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | $1.75 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +2.0% |
IPCX leads in 2 of 6 categories (Valuation Metrics, Risk & Volatility). LAZ leads in 1 (Total Returns). 1 tied.
IPCX vs LAZ: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Is IPCX or LAZ a better buy right now?
Lazard Ltd (LAZ) offers the better valuation at 22.
2x trailing P/E (16. 2x forward), making it the more compelling value choice. Analysts rate Lazard Ltd (LAZ) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — IPCX or LAZ?
Over the past 5 years, Lazard Ltd (LAZ) delivered a total return of +24.
8%, compared to -0. 1% for Inflection Point Acquisition Corp. III (IPCX). Over 10 years, the gap is even starker: LAZ returned +105. 3% versus IPCX's -0. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — IPCX or LAZ?
By beta (market sensitivity over 5 years), Inflection Point Acquisition Corp.
III (IPCX) is the lower-risk stock at 0. 04β versus Lazard Ltd's 1. 78β — meaning LAZ is approximately 4106% more volatile than IPCX relative to the S&P 500.
04Which has better profit margins — IPCX or LAZ?
Lazard Ltd (LAZ) is the more profitable company, earning 7.
4% net margin versus 0. 0% for Inflection Point Acquisition Corp. III — meaning it keeps 7. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LAZ leads at 13. 0% versus 0. 0% for IPCX. At the gross margin level — before operating expenses — LAZ leads at 31. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — IPCX or LAZ?
In this comparison, LAZ (3.
6% yield) pays a dividend. IPCX does not pay a meaningful dividend and should not be held primarily for income.
06Is IPCX or LAZ better for a retirement portfolio?
For long-horizon retirement investors, Inflection Point Acquisition Corp.
III (IPCX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 04)). Lazard Ltd (LAZ) carries a higher beta of 1. 78 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IPCX: -0. 1%, LAZ: +105. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between IPCX and LAZ?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: IPCX is a small-cap quality compounder stock; LAZ is a small-cap income-oriented stock. LAZ pays a dividend while IPCX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.